1887

Abstract

Individual strains of group A streptococci (GAS) differ in virulence, but the reasons for these differences are incompletely understood. To determine if the ability of GAS to cause invasive disease corresponded with their capacity to adhere to or invade epithelial cells, 63 clinical isolates of GAS (40 from patients with systemic infection and 23 from superficial disease) were examined in quantitative assays of bacterial adhesion to and invasion of HEp-2 cells, a continuous line of human pharyngeal epithelial cells. The results showed that individual isolates of GAS varied considerably in their ability to adhere to and penetrate HEp-2 cells. However, on the whole, strains from patients with invasive disease adhered to cells in numbers 1.5 greater than those from superficial infection. Paradoxically, strains from patients with invasive disease invaded HEp-2 cells to a significantly lesser extent than those from superficial sites, with a two-fold difference in invasion index (defined as the percentage of cell-associated bacteria located intracellularly). To determine if these differences were caused by differences in the production of hyaluronic acid capsule or M protein by the two groups of bacteria, the adherence and invasive capacities of bacteria carrying defined mutations in the genes for these factors were examined. Although M18-protein-deficient bacteria were less adherent to HEp-2 cells than the wild-type, neither the hyaluronic acid capsule nor the M protein had a significant influence on the ability of GAS to adhere to or invade HEp-2 cells. The results of this study demonstrate that there are biological differences between GAS isolates associated with invasive and superficial diseases and that these differences can be demonstrated by an assay of bacterial adherence to and invasion of HEp-2 epithelial cells.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/00222615-47-10-899
1998-10-01
2024-04-19
Loading full text...

Full text loading...

/deliver/fulltext/jmm/47/10/medmicro-47-10-899.html?itemId=/content/journal/jmm/10.1099/00222615-47-10-899&mimeType=html&fmt=ahah

References

  1. Curtis N. Invasive group A streptococcal infection. Curr Opin Infect Dis 1996; 9:191–202
    [Google Scholar]
  2. Stevens D. L. Invasive group A streptococcal disease. Infect Agents Dis 1996; 5:157–166
    [Google Scholar]
  3. Wessels M. R. Group A streptococcal disease in the 1990s: new clues to pathogenesis. Int J Infect Dis 1996; 1:107–114
    [Google Scholar]
  4. Ferrieri P. Microbiological features of current virulent strains of group A streptococci. Pediatr Infect Dis J 1991; 10: (10 Suppl) S20–S24
    [Google Scholar]
  5. Martin P. R., Hoiby E. A. Streptococcal serogroup A epidemic in Norway 1987–1988. Scand J Infect Dis 1990; 22:421–429
    [Google Scholar]
  6. Johnson D. R., Stevens D. L., Kaplan E. L. Epidemiologic analysis of group A streptococcal serotypes associated with severe systemic infections, rheumatic fever, or uncomplicated pharyngitis. J Infect Dis 1992; 166:374–382
    [Google Scholar]
  7. Chaussee M. S., Liu J., Stevens D. L., Ferretti J. J. Genetic and phenotypic diversity among isolates of Streptococcus pyogenes from invasive infections. J Infect Dis 1996; 173:901–908
    [Google Scholar]
  8. Greco R., De Martino L., Donnarumma G., Conte M. P., Seganti L., Valenti P. Invasion of cultured human cells by Streptococcus pyogenes. Res Microbiol 1995; 146:551–560
    [Google Scholar]
  9. LaPenta D., Rubens C., Chi E., Cleary P. P. Group A streptococci efficiently invade human respiratory epithelial cells. Proc Natl Acad Sci USA 1994; 91:12115–12119
    [Google Scholar]
  10. österlund A., Engstrand L. Intracellular penetration and survival of Streptococcus pyogenes in respiratory epithelial cells in vitro. Acta Otolaryngol (Stockh) 1995; 115:685–688
    [Google Scholar]
  11. Molinari G., Talay S. R., Valentin-Weigand P., Rohde M., Chhatwal G. S. The fibronectin-binding protein of Streptococcus pyogenes, SfbI, is involved in the internalization of group A streptococci by epithelial cells. Infect Immun 1997; 65:1357–1363
    [Google Scholar]
  12. Carapetis J., Robins-Browne R. M., Martin D., Shelby-James T., Hogg G. Increasing severity of invasive group A streptococcal disease in Australia: clinical and molecular epidemiological features and identification of a new virulent M-nontypable clone. Clin Infect Dis 1995; 21:1220–1227
    [Google Scholar]
  13. Wessels M. R., Moses A. E., Goldberg J. B., DiCesare T. J. Hyaluronic acid capsule is a virulence factor for mucoid group A streptococci. Proc Natl Acad Sci USA 1991; 88:8317–8321
    [Google Scholar]
  14. Wessels M. R., Bronze M. S. Critical role of the group A streptococcal capsule in pharyngeal colonization and infection in mice. Proc Natl Acad Sci USA 1994; 91:12238–12242
    [Google Scholar]
  15. Caparon M. G., Stephens D. S., Olsen A., Scott J. R. Role of M protein in adherence of group A streptococci. Infect Immun 1991; 59:1811–1817
    [Google Scholar]
  16. Norgren M., Caparon M. G., Scott J. R. A method for allelic replacement that uses the conjugative transposon Tn916: deletion of the emm6.1 allele in Streptococcus pyogenes JRS4. Infect Immun 1989; 57:3846–3850
    [Google Scholar]
  17. Robins-Browne R. M., Bennett-Wood V. Quantitative assessment of the ability of Escherichia coli to invade cultured animal cells. Microb Pathog 1992; 12:159–164
    [Google Scholar]
  18. Tran P.-O. T., Johnson D. R., Kaplan E. L. The presence of M protein in nontypeable group A streptococci upper respiratory tract isolates from southeast Asia. J Infect Dis 1994; 169:658–661
    [Google Scholar]
  19. Hollingshead S. K., Simecka J. W., Michalek S. M. Role of M protein in pharyngeal colonization by group A streptococci in rats. Infect Immun 1993; 61:2277–2283
    [Google Scholar]
  20. Wang J.-R., Stinson M. W. M protein mediates streptococcal adhesion to HEp-2 cells. Infect Immun 1994; 62:442–448
    [Google Scholar]
  21. Valentin-Weigand P., Chhatwal G. S. Correlation of epithelial cell invasiveness of group B streptococci with clinical source of isolation. Microb Pathog 1995; 19:83–91
    [Google Scholar]
  22. Fischetti V. A. Streptococcal M protein: molecular design and biological behavior. Clin Microbiol Rev 1989; 2:285–314
    [Google Scholar]
  23. Schwartz B., Facklam R. R., Breiman R. F. Changing epidemiology of group A streptococcal infection in the USA. Lancet 1990; 336:1167–1171
    [Google Scholar]
  24. Liu S., Courtney H. S., Bessen D. E., Hasty D. L., Dale J. B. M protein expression is not required for resistance to phagocytosis of type 18 group A streptococci. In Horaud T., Bouvet A., Leclercq R., de Montclos H., Sicard M. (eds) Streptococci and the host New York: Plenum Adv Exp Med Biol; 1997; 418725–727
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/00222615-47-10-899
Loading
/content/journal/jmm/10.1099/00222615-47-10-899
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error